Medtronic reports solid Q4 earnings, shares steady ahead August update
30.06.2026 - 14:01:36 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 14:01.
Medtronic plc (IE00BTN1Y115) closed the fiscal 2026 fourth quarter with earnings and revenues slightly above consensus, while its NYSE-listed shares trade in a narrow band around 81 dollars. The weekday focus today is the analyst consensus picture ahead the next estimated earnings date in mid-August.
What the latest earnings show
For its fiscal Q4 2026, Medtronic reported adjusted earnings of $1.55 per share, down 4.3 percent year on year but a $0.01 beat versus the $1.54 consensus estimate, according to analyst data compiled by MarketBeat and Zacks.
Quarterly revenue reached $9.81 billion, up 9.9 percent compared with the prior-year period and above the roughly $9.62 billion consensus figure, driven by firm procedure volumes in key franchises including Cardiac Ablation Solutions, which posted markedly strong growth.
Analysts' view on guidance and valuation
For full-year fiscal 2026, Medtronic delivered adjusted EPS of $5.53, a modest 0.7 percent increase year on year, while full-year revenue rose 8.4 percent to about $36.4 billion, placing the stock on a trailing price-earnings multiple around the low-20s and a forward multiple in the mid-teens on current estimates.
MarketBeat data show a projected EPS increase from roughly $5.94 to $6.38 in the next year, implying anticipated earnings growth of about 7 percent on current analyst models, while some commentary continues to frame the stock as reasonably valued relative to faster-growing medtech peers.
Background and price data on the Medtronic shares
Further news, consensus updates and price information on the Medtronic stock are available via the dedicated topic page and the company’s investor relations site.
How Medtronic makes its money
Medtronic generates its revenue primarily from medical devices and therapies in cardiovascular, neuroscience, diabetes and medical-surgical segments, with core products including implantable cardiac pacemakers and defibrillators, cardiac ablation systems for atrial fibrillation, insulin pumps and surgical tools used in hospitals worldwide.
Where the shares trade today
The Medtronic shares (IE00BTN1Y115) trade on 2026-06-30, 14:01, on the NYSE at around $81 per share, placing the company’s equity firmly within the large-cap U.S. medtech cohort.
Key data on the Medtronic shares
- Company: Medtronic plc
- ISIN: IE00BTN1Y115
- WKN: A14M2J
- Ticker: MDT
- Trading venue: NYSE
- Price (as of 2026-06-30, 14:01): 81.00 USD
- Market cap: approximately 108 billion USD (as of 2026-06-30)
- Sector / industry: Health Care Equipment & Supplies (medical technology)
- Index membership: S&P 500
- Next earnings date: estimated 2026-08-18
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a buy or sell recommendation, or a solicitation to trade any financial instrument. All data are based on sources believed to be reliable at the time of review but may change without notice.
